71
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Essential thrombocytemia and acute coronary syndrome: clinical profile and association with other thromboembolic events

, &
Pages 116-120 | Received 08 May 2007, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

María Luisa Antelo, Natalia de las Heras, Jose Ramón Gonzalez Porras, Ana Kerguelen & Jose María Raya. (2015) Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide. Expert Review of Hematology 8:6, pages 819-835.
Read now
Rafael Beyar. (2008) Acute Cardiac Care – Flow, Function and Beyond. Acute Cardiac Care 10:2, pages 67-68.
Read now

Articles from other publishers (5)

Masafumi Sugawara, Sho Okada, Masato Kanda, Tohru Iseki, Emiko Sakaida & Yoshio Kobayashi. (2022) Anagrelide-associated Cardiomyopathy and Heart Failure in a Patient with Essential Thrombocythemia: A Case Report and Literature Review. Internal Medicine 61:21, pages 3293-3299.
Crossref
G. Tortorella, M. Calzolari, A. Tieghi, N. Muià, A. Piccin & L. Gugliotta. (2016) Acute coronary syndrome (ACS) in patients with essential thrombocytemia (ET). What is the best treatment?. International Journal of Cardiology 203, pages 225-227.
Crossref
Manuel Martínez-Sellés, Tomás Datino, Lourdes Figueiras-Graillet, Joubert G. Gama, Christopher Jones, Richard Franklin & Francisco Fernández-Avilés. (2012) Cardiovascular Safety of Anagrelide in Healthy Subjects: Effects of Caffeine and Food Intake on Pharmacokinetics and Adverse Reactions. Clinical Drug Investigation 33:1, pages 45-54.
Crossref
Carlos Besses & Manuel Martínez-Sellés. (2011) Anagrelide and cardiovascular events. Much ado about nothing?. Leukemia Research 35:12, pages 1543-1544.
Crossref
G. CAMPO, M. VALGIMIGLI, R. CARLETTI, L. FILETI & R. FERRARI. (2009) Long‐term outcome after percutaneous coronary intervention in patients with essential thrombocythemia. Journal of Thrombosis and Haemostasis 7:7, pages 1235-1238.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.